{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:33:28Z","timestamp":1780450408737,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":35,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.aohep.2025.101786","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T11:07:40Z","timestamp":1740222460000},"page":"101786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical spectrum and long-term outcomes of non-cirrhotic portal venous system thrombosis in Hispanic population"],"prefix":"10.1016","volume":"30","author":[{"given":"Fernando","family":"Gil-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2305-9638","authenticated-orcid":false,"given":"Fausto Alfredo","family":"Rios-Olais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0258-7397","authenticated-orcid":false,"given":"Roberta","family":"Demichelis-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Vargas-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Analy","family":"Mora-Ca\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia A.","family":"Mercado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise M.","family":"Harnois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Rangel-Pati\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.aohep.2025.101786_bib0001","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.01.265","article-title":"Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis","volume":"156","author":"Intagliata","year":"2019","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.aohep.2025.101786_bib0002","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.aohep.2025.101786_bib0003","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1365-2036.2010.04454.x","article-title":"The epidemiology and clinical features of portal vein thrombosis: a multicentre study","volume":"32","author":"Rajani","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.aohep.2025.101786_bib0004","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/hep.23259","article-title":"Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study","volume":"51","author":"Plessier","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.aohep.2025.101786_bib0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","article-title":"Clinical Practice Guidelines: Vascular diseases of the liver","volume":"64","year":"2016","journal-title":"J Hepatol"},{"issue":"No. 12","key":"10.1016\/j.aohep.2025.101786_bib0006","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200104","article-title":"Rivaroxaban prophylaxis in noncirrhotic portal vein thrombosis","volume":"1","author":"Plessier","year":"2022","journal-title":"NEJM Evid"},{"issue":"7","key":"10.1016\/j.aohep.2025.101786_bib0007","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.pathol.2022.09.001","article-title":"A review of laboratory considerations in thrombophilia testing","volume":"54","author":"Ong","year":"2022","journal-title":"Pathology"},{"key":"10.1016\/j.aohep.2025.101786_bib0008","doi-asserted-by":"crossref","unstructured":"Middeldorp S., Nieuwlaat R., Baumann Kreuziger L., et al. American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing. Blood Adv. Nov 28 2023;7(22):7101\u201338. doi:10.1182\/bloodadvances.2023010177","DOI":"10.1182\/bloodadvances.2023010177"},{"issue":"6","key":"10.1016\/j.aohep.2025.101786_bib0009","doi-asserted-by":"crossref","first-page":"851","DOI":"10.21149\/11547","article-title":"[Increase in medical offices in pharmacies in Mexico and health care in public healthservices between 2012 and 2018]","volume":"62","author":"Colchero","year":"2020","journal-title":"Salud Publica Mex"},{"key":"10.1016\/j.aohep.2025.101786_bib0010","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/1472-6963-14-186","article-title":"Effective access to health care in Mexico","volume":"14","author":"Gutierrez","year":"2014","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"10.1016\/j.aohep.2025.101786_bib0011","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/MBC.0000000000000518","article-title":"Primary thrombophilia in Mexico: a single tertiary referral hospital experience","volume":"27","author":"Lacayo-Lenero","year":"2016","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"10.1016\/j.aohep.2025.101786_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-8652(199901)60:1<1::AID-AJH1>3.0.CO;2-Q","article-title":"Primary thrombophilia in Mexico: a prospective study","volume":"60","author":"Ruiz-Arguelles","year":"1999","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.aohep.2025.101786_bib0013","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.aohep.2025.101786_bib0014","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1182\/asheducation-2016.1.208","article-title":"Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuria","volume":"2016","author":"Parker","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"10","key":"10.1016\/j.aohep.2025.101786_bib0015","first-page":"1899","article-title":"Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2 glycoprotein-I than with antiphospholipid antibodies","volume":"22","author":"Cabiedes","year":"1995","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.aohep.2025.101786_bib0016","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/cyto.b.20525","article-title":"Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry","volume":"78","author":"Borowitz","year":"2010","journal-title":"Cytometry B Clin Cytom"},{"issue":"20","key":"10.1016\/j.aohep.2025.101786_bib0017","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.aohep.2025.101786_bib0018","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1515\/cclm-2018-1041","article-title":"Danger of false negative (exclusion) or false positive (diagnosis) for 'congenital thrombophilia' in the age of anticoagulants","volume":"57","author":"Favaloro","year":"2019","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"10.1016\/j.aohep.2025.101786_bib0019","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/02841850510021157","article-title":"Imaging and radiological interventions of portal vein thrombosis","volume":"46","author":"Hidajat","year":"2005","journal-title":"Acta Radiol"},{"issue":"6","key":"10.1016\/j.aohep.2025.101786_bib0020","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2214\/ajr.157.6.1950868","article-title":"CT of acquired abnormalities of the spleen","volume":"157","author":"Taylor","year":"1991","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"10.1016\/j.aohep.2025.101786_bib0021","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1111\/jth.15048","article-title":"Definition of major bleeding: prognostic classification","volume":"18","author":"Franco","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"17","key":"10.1016\/j.aohep.2025.101786_bib0022","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMra1600561","article-title":"Hepatic encephalopathy","volume":"375","author":"Wijdicks","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.aohep.2025.101786_bib0023","doi-asserted-by":"crossref","first-page":"476","DOI":"10.5604\/01.3001.0011.7392","article-title":"Thrombosis of the portal venous system in cirrhotic vs. Non-cirrhotic patients","volume":"17","author":"Cruz-Ramon","year":"2018","journal-title":"Ann Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2025.101786_bib0024","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1055\/s-0028-1085096","article-title":"Extrahepatic portal vein thrombosis","volume":"28","author":"Garcia-Pagan","year":"2008","journal-title":"Semin Liver Dis"},{"issue":"4","key":"10.1016\/j.aohep.2025.101786_bib0025","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s11239-020-02090-y","article-title":"Thrombophilia screening revisited: an issue of personalized medicine","volume":"49","author":"Colucci","year":"2020","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"10.1016\/j.aohep.2025.101786_bib0026","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11899-018-0446-x","article-title":"Splanchnic vein thrombosis in the myeloproliferative neoplasms","volume":"13","author":"Akpan","year":"2018","journal-title":"Curr Hematol Malig Rep"},{"issue":"1","key":"10.1016\/j.aohep.2025.101786_bib0027","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jhep.2022.08.023","article-title":"Incidence and factors predictive of recurrent thrombosis in people with non-cirrhotic portal vein thrombosis","volume":"78","author":"Baiges","year":"2023","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2025.101786_bib0028","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1160\/TH16-10-0781","article-title":"Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome","volume":"117","author":"Ageno","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.aohep.2025.101786_bib0029","first-page":"2018","article-title":"Antiphospholipid syndrome presenting as acute mesenteric venous thrombosis involving a variant inferior mesenteric vein and successful treatment with rivaroxaban","author":"Singh","year":"2018","journal-title":"BMJ Case Rep"},{"issue":"Suppl 1","key":"10.1016\/j.aohep.2025.101786_bib0030","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0049-3848(17)30066-X","article-title":"Antiphospholipid syndrome","volume":"151","author":"Cervera","year":"2017","journal-title":"Thromb Res"},{"issue":"12","key":"10.1016\/j.aohep.2025.101786_bib0031","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2169\/internalmedicine.40.1245","article-title":"Portal and mesenteric vein and inferior vena cava thrombosis associated with antiphospholipid syndrome","volume":"40","author":"Higa","year":"2001","journal-title":"Intern Med"},{"issue":"4","key":"10.1016\/j.aohep.2025.101786_bib0032","first-page":"1019","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum","volume":"46","author":"Cervera","year":"2002","journal-title":"Apr"},{"issue":"5","key":"10.1016\/j.aohep.2025.101786_bib0033","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/hep.28466","article-title":"Natural history and management of esophagogastric varices in chronic noncirrhotic, nontumoral portal vein thrombosis","volume":"63","author":"Noronha Ferreira","year":"2016","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.aohep.2025.101786_bib0034","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1007\/s00268-011-1198-0","article-title":"Management of acute non-cirrhotic and non-malignant portal vein thrombosis: a systematic review","volume":"35","author":"Hall","year":"2011","journal-title":"World J Surg"},{"issue":"12","key":"10.1016\/j.aohep.2025.101786_bib0035","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cgh.2008.07.031","article-title":"Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation","volume":"6","author":"Turnes","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.aohep.2025.101786_bib0036","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.dld.2023.05.007","article-title":"Clinical outcomes and prognostic factors in non-cirrhotic non-neoplastic patients with portal vein thrombosis: a single-centre experience","volume":"55","author":"Gioia","year":"2023","journal-title":"Dig Liver Dis"},{"issue":"4","key":"10.1016\/j.aohep.2025.101786_bib0037","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2025.101786_bib0038","doi-asserted-by":"crossref","first-page":"100667","DOI":"10.1016\/j.jhepr.2022.100667","article-title":"Management of splanchnic vein thrombosis","volume":"5","author":"Elkrief","year":"2023","journal-title":"JHEP Rep."},{"issue":"5","key":"10.1016\/j.aohep.2025.101786_bib0039","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1055\/s-0040-1720979","article-title":"Hemorrhage in essential thrombocythemia or polycythemia vera: epidemiology, location, risk factors, and lessons learned from the literature","volume":"121","author":"Nicol","year":"2021","journal-title":"Thromb Haemost."},{"issue":"8","key":"10.1016\/j.aohep.2025.101786_bib0040","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3324\/haematol.2020.255117","article-title":"Acquired von Willebrand syndrome: focused for hematologists","volume":"105","author":"Franchini","year":"2020","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.aohep.2025.101786_bib0041","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/M19-0291","article-title":"Rivaroxaban versus vitamin K antagonist in antiphospholipid syndrome: a randomized noninferiority trial","volume":"171","author":"Ordi-Ros","year":"2019","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.aohep.2025.101786_bib0042","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.autrev.2018.04.009","article-title":"Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis","volume":"17","author":"Dufrost","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"13","key":"10.1016\/j.aohep.2025.101786_bib0043","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome","volume":"132","author":"Pengo","year":"2018","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.aohep.2025.101786_bib0044","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood.2024023988","article-title":"Paroxysmal nocturnal hemoglobinuria-related thrombosis in the era of novel therapies: a 2043-patient-year analysis","volume":"144","author":"Gurnari","year":"2024","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.aohep.2025.101786_bib0045","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/bjh.12099","article-title":"Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population","volume":"160","author":"Nielsen","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.aohep.2025.101786_bib0046","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12959-018-0187-z","article-title":"Splanchnic venous thrombosis in JAK2 V617F mutation positive myeloproliferative neoplasms - long term follow-up of a regional case series","volume":"16","author":"Greenfield","year":"2018","journal-title":"Thromb J"},{"issue":"11","key":"10.1016\/j.aohep.2025.101786_bib0047","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/j.1572-0241.2007.01477.x","article-title":"Prognostic factors in noncirrhotic patients with splanchnic vein thromboses","volume":"102","author":"Amitrano","year":"2007","journal-title":"Am J Gastroenterol"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125000109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125000109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T04:36:14Z","timestamp":1777782974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268125000109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1665268125000109"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2025.101786","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical spectrum and long-term outcomes of non-cirrhotic portal venous system thrombosis in Hispanic population","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2025.101786","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101786"}}